Loss-of-function mutations in TP53 and NOTCH1 are known to provide a fitness advantage to epithelial cells40,46,47, but our findings suggest their contribution to tumor progression may primarily stem from the mutator phenotypes that they induce. Here, TP53 is linked to neoplasm.